# Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery

> **NCT07238972** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Yonsei University** · enrollment: 180 (estimated)

## Conditions studied

- Anemia
- Iron Deficiencies
- Iron Deficiency Anemia
- Cardiac Surgery
- Heart Valve Diseases

## Interventions

- **DRUG:** Ferric derisomaltose
- **DRUG:** Placebo (0.9% saline)

## Key facts

- **NCT ID:** NCT07238972
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2030-08
- **Final completion:** 2030-10
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07238972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07238972, "Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07238972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*